377 related articles for article (PubMed ID: 15197807)
41. Phase I trial of intrathecal spartaject busulfan in children with neoplastic meningitis: a Pediatric Brain Tumor Consortium Study (PBTC-004).
Gururangan S; Petros WP; Poussaint TY; Hancock ML; Phillips PC; Friedman HS; Bomgaars L; Blaney SM; Kun LE; Boyett JM
Clin Cancer Res; 2006 Mar; 12(5):1540-6. PubMed ID: 16533779
[TBL] [Abstract][Full Text] [Related]
42. Efficacy and feasibility of procarbazine, ranimustine and vincristine chemotherapy, and the role of surgical resection in anaplastic oligodendroglioma.
Yamamoto M; Iwaasa M; Nonaka M; Tsugu H; Nabeshima K; Fukushima T
Anticancer Res; 2005; 25(6A):3715-23. PubMed ID: 16302731
[TBL] [Abstract][Full Text] [Related]
43. Children treated with metronomic chemotherapy in a low-income country: METRO-MALI-01.
Fousseyni T; Diawara M; Pasquier E; André N
J Pediatr Hematol Oncol; 2011 Jan; 33(1):31-4. PubMed ID: 21164360
[TBL] [Abstract][Full Text] [Related]
44. Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma.
Kushner BH; Kramer K; LaQuaglia MP; Modak S; Yataghene K; Cheung NK
J Clin Oncol; 2004 Dec; 22(24):4888-92. PubMed ID: 15611504
[TBL] [Abstract][Full Text] [Related]
45. Pediatric phase I trial and pharmacokinetic study of the platelet-derived growth factor (PDGF) receptor pathway inhibitor SU101.
Adamson PC; Blaney SM; Widemann BC; Kitchen B; Murphy RF; Hannah AL; Cropp GF; Patel M; Gillespie AF; Whitcomb PG; Balis FM
Cancer Chemother Pharmacol; 2004 Jun; 53(6):482-8. PubMed ID: 14999430
[TBL] [Abstract][Full Text] [Related]
46. Chemotherapy with cisplatin and vincristine for optic pathway/hypothalamic astrocytoma in young children.
Sawamura Y; Kamoshima Y; Kato T; Tajima T; Tsubaki J
Jpn J Clin Oncol; 2009 May; 39(5):277-83. PubMed ID: 19224939
[TBL] [Abstract][Full Text] [Related]
47. A phase 2 feasibility study of sequential, dose intensive chemotherapy to treat progressive low-grade gliomas in children.
Bruggers CS; Greene D
J Pediatr Hematol Oncol; 2007 Sep; 29(9):602-7. PubMed ID: 17805033
[TBL] [Abstract][Full Text] [Related]
48. A Phase I study of concurrent RMP-7 and carboplatin with radiation therapy for children with newly diagnosed brainstem gliomas.
Packer RJ; Krailo M; Mehta M; Warren K; Allen J; Jakacki R; Villablanca JG; Chiba A; Reaman G
Cancer; 2005 Nov; 104(9):1968-74. PubMed ID: 16177987
[TBL] [Abstract][Full Text] [Related]
49. Phase I study of fotemustine in pediatric patients with refractory brain tumors.
Hargrave DR; Bouffet E; Gammon J; Tariq N; Grant RM; Baruchel S
Cancer; 2002 Sep; 95(6):1294-301. PubMed ID: 12216098
[TBL] [Abstract][Full Text] [Related]
50. Pharmacokinetic comparison of oral and intravenous etoposide in patients treated with the CHOEP-regimen for malignant lymphomas.
Kroschinsky FP; Friedrichsen K; Mueller J; Pursche S; Haenel M; Prondzinsky R; Ehninger G; Schleyer E
Cancer Chemother Pharmacol; 2008 Apr; 61(5):785-90. PubMed ID: 17579865
[TBL] [Abstract][Full Text] [Related]
51. Favorable outcome of Ewing sarcoma family tumors to multiagent intensive preoperative chemotherapy: a single institution experience.
Moschovi M; Trimis G; Stefanaki K; Anastasopoulos J; Syriopoulou V; Koultouki E; Tzortzatou-Stathopoulou F
J Surg Oncol; 2005 Mar; 89(4):239-43. PubMed ID: 15726621
[TBL] [Abstract][Full Text] [Related]
52. High-dose-rate brachytherapy as part of a multidisciplinary treatment of nasopharyngeal lymphoepithelioma in childhood.
Nakamura RA; Novaes PE; Antoneli CB; Fogaroli RC; Pellizzon AC; Ferrigno R; Maia MA; Salvajoli JV; Pereira AJ; Nishimoto IN
Cancer; 2005 Aug; 104(3):525-31. PubMed ID: 15986481
[TBL] [Abstract][Full Text] [Related]
53. Intraarterial chemotherapy and osmotic blood-brain barrier disruption for patients with embryonal and germ cell tumors of the central nervous system.
Jahnke K; Kraemer DF; Knight KR; Fortin D; Bell S; Doolittle ND; Muldoon LL; Neuwelt EA
Cancer; 2008 Feb; 112(3):581-8. PubMed ID: 18072268
[TBL] [Abstract][Full Text] [Related]
54. Differential impact of high-dose cyclophosphamide, topotecan, and vincristine in clinical subsets of patients with chemoresistant neuroblastoma.
Kushner BH; Kramer K; Modak S; Qin LX; Cheung NK
Cancer; 2010 Jun; 116(12):3054-60. PubMed ID: 20564411
[TBL] [Abstract][Full Text] [Related]
55. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?
Nieder C; Andratschke N; Wiedenmann N; Busch R; Grosu AL; Molls M
Strahlenther Onkol; 2004 Jul; 180(7):401-7. PubMed ID: 15241527
[TBL] [Abstract][Full Text] [Related]
56. A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma.
Micallef IN; Kahl BS; Maurer MJ; Dogan A; Ansell SM; Colgan JP; Geyer S; Inwards DJ; White WL; Habermann TM
Cancer; 2006 Dec; 107(12):2826-32. PubMed ID: 17099879
[TBL] [Abstract][Full Text] [Related]
57. Serial intense chemotherapy combining topotecan, etoposide, carboplatin and cyclophosphamide (TECC) followed by autologous hematopoietic stem cell support in patients with high risk soft tissue sarcoma (STS).
Bernbeck B; Bahci S; Meisel R; Troeger A; Schönberger S; Laws HJ; Kramm C; Wessalowski R; Koscielniak E; Dilloo D; Göbel U
Klin Padiatr; 2007; 219(6):318-22. PubMed ID: 18050041
[TBL] [Abstract][Full Text] [Related]
58. Efficacy of topotecan and cyclophosphamide given in a phase II window trial in children with newly diagnosed metastatic rhabdomyosarcoma: a Children's Oncology Group study.
Walterhouse DO; Lyden ER; Breitfeld PP; Qualman SJ; Wharam MD; Meyer WH
J Clin Oncol; 2004 Apr; 22(8):1398-403. PubMed ID: 15007087
[TBL] [Abstract][Full Text] [Related]
59. Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma.
Chi SN; Gardner SL; Levy AS; Knopp EA; Miller DC; Wisoff JH; Weiner HL; Finlay JL
J Clin Oncol; 2004 Dec; 22(24):4881-7. PubMed ID: 15611503
[TBL] [Abstract][Full Text] [Related]
60. Pilot study of high-dose, concurrent biochemotherapy for advanced melanoma.
Kim KB; Eton O; East MJ; Hodges C; Papadopoulos NE; Grimm EA; Bedikian AY
Cancer; 2004 Aug; 101(3):596-603. PubMed ID: 15274073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
